Form 4: Clearfield CFO Receives 11,495 Restricted Stock Shares

Clearfield, Inc.'s Chief Financial Officer, Daniel R. Herzog, was granted 11,495 shares of restricted stock, aligning executive interests with long-term company performance.

Summary

• Daniel R. Herzog, Chief Financial Officer of Clearfield, Inc. (CLFD), was granted 11,495 shares of restricted stock.
• The transaction date for this acquisition was November 28, 2025.
• The restricted stock was acquired at a price of $0 per share, which is typical for such grants.
• Following this transaction, Daniel R. Herzog beneficially owns 84,994 shares directly.
• The restricted stock vests in three equal tranches: one-third on November 16, 2026, one-third on November 16, 2027, and the final one-third on November 16, 2028.
• Vesting is contingent upon Daniel R. Herzog's continued employment with Clearfield, Inc. through each respective vesting date.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key executive is generally a positive for aligning management incentives with shareholder interests and for executive retention, though it is a routine compensation event that does not significantly alter the company's fundamental outlook.

Positives

• The grant of restricted stock aligns the Chief Financial Officer's long-term financial interests with those of the shareholders, incentivizing sustained company performance.
• This equity grant serves as a retention mechanism, encouraging the CFO to remain with the company through the multi-year vesting period.

Risks

• The vesting of the restricted stock is subject to the reporting person's continued employment through each vesting date, meaning the shares could be forfeited if employment ceases prematurely.

Future Outlook

The multi-year vesting schedule for the restricted stock grant, extending through November 2028, indicates a long-term incentive structure designed to retain the Chief Financial Officer and align their performance with the company's future strategic objectives and shareholder value creation.

Industry Context

This restricted stock grant to a key executive is a standard practice within the industry for executive compensation. It is commonly used to incentivize long-term performance, foster executive retention, and align management's financial interests with those of the company's shareholders, particularly in technology and growth-oriented sectors.

Comparison to Industry Standards

• Restricted stock grants are a common form of equity compensation for executives across various industries, including the telecommunications and fiber optic sectors where Clearfield operates.
• The multi-year vesting schedule (three years) is consistent with typical executive incentive programs designed to promote long-term commitment and align interests with shareholder value creation.
• The grant size, relative to the executive's role and total compensation, appears to be within the normal range for a Chief Financial Officer at a company of Clearfield's size and market capitalization, comparable to similar grants observed at peers like CommScope or Corning.

Stakeholder Impact

• Shareholders: The grant aligns the CFO's interests with long-term shareholder value creation.
• Employees (CFO): Provides a significant equity-based compensation component, incentivizing continued employment and performance.

Next Steps

• Vesting of one-third of the restricted stock shares on November 16, 2026.
• Vesting of one-third of the restricted stock shares on November 16, 2027.
• Vesting of the final one-third of the restricted stock shares on November 16, 2028.

Key Dates

Recommendation

This Form 4 reports a routine restricted stock grant to a key executive, which is a standard component of compensation designed to align management interests with long-term shareholder value. It does not present new information that would fundamentally alter the investment thesis or warrant a change in stock recommendation.

Keywords

Clearfield, CLFD, Restricted Stock, CFO, Insider Transaction, Equity Grant, Executive Compensation, Form 4